Detalles de la búsqueda
1.
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature
; 596(7870): 126-132, 2021 08.
Artículo
Inglés
| MEDLINE | ID: mdl-34290408
2.
Genome-wide cell-free DNA fragmentation in patients with cancer.
Nature
; 570(7761): 385-389, 2019 06.
Artículo
Inglés
| MEDLINE | ID: mdl-31142840
3.
The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer.
Cancer Metastasis Rev
; 41(2): 347-366, 2022 06.
Artículo
Inglés
| MEDLINE | ID: mdl-35876944
4.
Cardiovascular complications of immune checkpoint inhibitors for cancer.
Eur Heart J
; 43(42): 4458-4468, 2022 11 07.
Artículo
Inglés
| MEDLINE | ID: mdl-36040835
5.
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.
Oncologist
; 27(11): 971-981, 2022 11 03.
Artículo
Inglés
| MEDLINE | ID: mdl-35972337
6.
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors.
Cancer Immunol Immunother
; 71(10): 2405-2420, 2022 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-35217892
7.
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature
; 598(7881): E1, 2021 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-34608287
8.
Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies.
Oncologist
; 26(10): e1822-e1832, 2021 10.
Artículo
Inglés
| MEDLINE | ID: mdl-34251728
9.
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
N Engl J Med
; 378(21): 1976-1986, 2018 May 24.
Artículo
Inglés
| MEDLINE | ID: mdl-29658848
10.
Real-World Incidence and Management of Immune-Related Adverse Events from Immune Checkpoint Inhibitors: Retrospective Claims-Based Analysis.
Cancer Invest
; 39(10): 789-796, 2021 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-33829943
11.
Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research.
Lancet Oncol
; 21(8): e398-e404, 2020 08.
Artículo
Inglés
| MEDLINE | ID: mdl-32758477
12.
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation.
Ann Rheum Dis
; 79(3): 332-338, 2020 03.
Artículo
Inglés
| MEDLINE | ID: mdl-31540935
13.
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.
J Natl Compr Canc Netw
; 18(3): 230-241, 2020 03.
Artículo
Inglés
| MEDLINE | ID: mdl-32135517
14.
Checkpoint Inhibitor Pneumonitis: Mechanisms, Characteristics, Management Strategies, and Beyond.
Curr Oncol Rep
; 22(6): 56, 2020 05 16.
Artículo
Inglés
| MEDLINE | ID: mdl-32415399
15.
Lung cancer and family-centered concerns.
Support Care Cancer
; 28(2): 497-505, 2020 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-31065838
16.
Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor-related Pneumonitis. An Official American Thoracic Society Research Statement.
Am J Respir Crit Care Med
; 200(6): e31-e43, 2019 09 15.
Artículo
Inglés
| MEDLINE | ID: mdl-31518182
17.
A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse Events.
J Natl Compr Canc Netw
; 17(6): 712-720, 2019 06 01.
Artículo
Inglés
| MEDLINE | ID: mdl-31200355
18.
Management of Immunotherapy-Related Toxicities, Version 1.2019.
J Natl Compr Canc Netw
; 17(3): 255-289, 2019 03 01.
Artículo
Inglés
| MEDLINE | ID: mdl-30865922
19.
Correction to: The gut microbiome, immune check point inhibition and immunerelated adverse events in nonsmall cell lung cancer.
Cancer Metastasis Rev
; 2022 Aug 19.
Artículo
Inglés
| MEDLINE | ID: mdl-35982190
20.
Rediagnosis of Lung Cancer as NUT Midline Carcinoma Based on Clues From Tumor Genomic Profiling.
J Natl Compr Canc Netw
; 16(5): 467-472, 2018 05.
Artículo
Inglés
| MEDLINE | ID: mdl-29752320